<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02478983</url>
  </required_header>
  <id_info>
    <org_study_id>995.7</org_study_id>
    <nct_id>NCT02478983</nct_id>
  </id_info>
  <brief_title>A Randomized Comparison of LMA (Laryngeal Mask Airway) Supreme and LMA Proseal in Infants Below 10kg</brief_title>
  <official_title>A Randomized Comparison of LMA Supreme and LMA Proseal in Infants Below 10kg</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Malaya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Malaya</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators conduct this study to evaluate the clinical efficacy of size 1 and 1.5
      supreme LMA compared to proseal LMA for infants weighing &lt;10kg.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized prospective study to compare the clinical efficacy and safety for size 1
      and 1.5 LMA supreme and LMA Proseal. The airway leak pressure of these 2 devices will be
      compared and other parameters such as time to insertion, insertion success rate, fibreoptic
      glottic view and intraoperative complications will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oropharyngeal leak pressure</measure>
    <time_frame>intraoperative</time_frame>
    <description>The measurement of oropharyngeal airway pressure when airway leak occurred</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insertion success rate</measure>
    <time_frame>intraoperative</time_frame>
    <description>The number of attempts for successful placement of the supraglottic airway is recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibreoptic glottis view</measure>
    <time_frame>intraoperative</time_frame>
    <description>Fibreoptic glottis view will be recorded according to a grading system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative complications</measure>
    <time_frame>intraoperative</time_frame>
    <description>Complications such as loss of airway patency, desaturation, regurgitation of gastric contents, laryngospasm, bronchospasm and airway trauma will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to insertion</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Laryngeal Mask Airway</condition>
  <arm_group>
    <arm_group_label>LMA Supreme</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 arm will receive LMA supreme for airway management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LMA Proseal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 arm will receive LMA Proseal for airway management</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LMA Supreme</intervention_name>
    <description>The device will be inserted according to manufacturer's guideline. Time of insertion will be recorded. The oropharyngeal airway leak pressure will be measured when the device successfully inserted. The time taken to insert the LMA is recorded and the insertion success rate is documented. The larynx will be visualized with fibreoptic bronchoscope inserted through the LMA. Intraoperative complications will be recorded.</description>
    <arm_group_label>LMA Supreme</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LMA Proseal</intervention_name>
    <description>The device will be inserted according to manufacturer's guideline. Time of insertion will be recorded. The oropharyngeal airway leak pressure will be measured when the device successfully inserted. The time taken to insert the LMA is recorded and the insertion success rate is documented. The larynx will be visualized with fibreoptic bronchoscope inserted through the LMA. Intraoperative complications will be recorded.</description>
    <arm_group_label>LMA Proseal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Weight of &lt; 10kg

          -  ASA (American Society of Anesthesiologists) I-II

          -  Infants undergoing elective surgery under general anaesthesia using supraglottic
             airway device.

          -  Informed consent obtained from parents.

        Exclusion Criteria:

          -  ASA III-IV and emergency surgery

          -  Neonates and ex-premature babies with post conceptual age &lt;55 weeks.

          -  Infants with history of difficult airway.

          -  Infants with features of difficult intubation.

          -  Active upper respiratory tract infection

          -  Infants with pulmonary disease

          -  Infants with history of gastroesophageal reflux disease

          -  Infants with risks of regurgitation and aspiration.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sook Hui Chaw, M.Med</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Malaya</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine, University of Malaya</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Wilayah Persekutuan</state>
        <zip>50603</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2015</study_first_submitted>
  <study_first_submitted_qc>June 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2015</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Malaya</investigator_affiliation>
    <investigator_full_name>Chaw Sook Hui</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

